|
Immersion Foot
|
D007102 |
[A condition of the feet produced by prolonged exposure of the feet to water. Exposure for 48 hours or more to warm water causes tropical immersion foot or warm-water immersion foot common in Vietnam where troops were exposed to prolonged or repeated wading in paddy fields or streams. Trench foot results from prolonged exposure to cold, without actual freezing. It was common in trench warfare during World War I, when soldiers stood, sometimes for hours, in trenches with a few inches of cold water in them. (Andrews' Diseases of the Skin, 8th ed, p27)
] |
|
Immobility Response, Tonic
|
D046353 |
[An induced response to threatening stimuli characterized by complete loss of muscle strength.
] |
|
Immobilization
|
D007103 |
[The restriction of the MOVEMENT of whole or part of the body by physical means (RESTRAINT, PHYSICAL) or chemically by ANALGESIA, or the use of TRANQUILIZING AGENTS or NEUROMUSCULAR NONDEPOLARIZING AGENTS. It includes experimental protocols used to evaluate the physiologic effects of immobility.
] |
|
Immobilized Nucleic Acids
|
D061925 |
[DNA or RNA bound to a substrate thereby having fixed positions.
] |
|
Immobilized Proteins
|
D055767 |
[Proteins that are chemically bound to a substrate material which renders their location fixed. The immobilization of proteins allows their use in chemical reactions without being diluted by solvent.
] |
|
Immune Adherence Reaction
|
D007104 |
[A method for the detection of very small quantities of antibody in which the antigen-antibody-complement complex adheres to indicator cells, usually primate erythrocytes or nonprimate blood platelets. The reaction is dependent on the number of bound C3 molecules on the C3b receptor sites of the indicator cell.
] |
|
Immune Checkpoint Inhibitors
|
D000082082 |
[Drugs that block negative regulator IMMUNE CHECKPOINT proteins (e.g., PD-1 RECEPTOR and CTLA-4 ANTIGEN) thereby increasing suppressed immune activation in immunotherapies.
] |
|
Immune Checkpoint Proteins
|
D000082102 |
[Immunomodulators that regulate immune system either in stimulatory or inhibitory fashion allowing IMMUNE TOLERANCE. Activation of suppressed immune system (IMMUNOSUPPRESSION (PHYSIOLOGY)) in immunotherapy by IMMUNE CHECKPOINT INHIBITORS often targets inhibitory checkpoint molecules.
] |
|
Immune Complex Diseases
|
D007105 |
[Group of diseases mediated by the deposition of large soluble complexes of antigen and antibody with resultant damage to tissue. Besides SERUM SICKNESS and the ARTHUS REACTION, evidence supports a pathogenic role for immune complexes in many other IMMUNE SYSTEM DISEASES including GLOMERULONEPHRITIS, systemic lupus erythematosus (LUPUS ERYTHEMATOSUS, SYSTEMIC) and POLYARTERITIS NODOSA.
] |
|
Immune Evasion
|
D057131 |
[Methods used by pathogenic organisms to evade a host's immune system.
] |
|
Immune Privilege
|
D000073860 |
[Phenomenon which occurs in certain tissue sites and organs (e.g., the ANTERIOR CHAMBER and CORNEA of the eye, brain PARENCHYMAL TISSUE and fetus) to tolerate a known antigen, thereby suppressing the inflammatory immune response. Foreign tissue grafts survive for prolonged periods when placed within such immune privileged sites and organs.
] |
|
Immune Reconstitution
|
D000074243 |
[Regeneration of normal immune function after immune depleting procedures or infections (e.g., HEMATOPOIETIC STEM CELL TRANSPLANTATION). Delayed and incomplete reconstitution of the ADAPTIVE IMMUNE system in particular involving T-CELLS is associated with increase or relapse of infection.
] |
|
Immune Reconstitution Inflammatory Syndrome
|
D054019 |
[Exuberant inflammatory response towards a previously acquired or undiagnosed opportunistic infection. It is frequently seen in AIDS patients following antiretroviral treatment.
] |
|
Immune Sera
|
D007106 |
[Serum that contains antibodies. It is obtained from an animal that has been immunized either by ANTIGEN injection or infection with microorganisms containing the antigen.
] |
|
Immune System
|
D007107 |
[The body's defense mechanism against foreign organisms or substances and deviant native cells. It includes the humoral immune response and the cell-mediated response and consists of a complex of interrelated cellular, molecular, and genetic components.
] |
|
Immune System Diseases
|
D007154 |
[Disorders caused by abnormal or absent immunologic mechanisms, whether humoral, cell-mediated, or both.
] |
|
Immune System Phenomena
|
D055633 |
[The characteristic properties and processes involved in IMMUNITY and an organism's immune response.
] |
|
Immune Tolerance
|
D007108 |
[The specific failure of a normally responsive individual to make an immune response to a known antigen. It results from previous contact with the antigen by an immunologically immature individual (fetus or neonate) or by an adult exposed to extreme high-dose or low-dose antigen, or by exposure to radiation, antimetabolites, antilymphocytic serum, etc.
] |
|
Immunity
|
D007109 |
[Nonsusceptibility to the invasive or pathogenic effects of foreign microorganisms or to the toxic effect of antigenic substances.
] |
|
Immunity, Active
|
D007110 |
[Resistance to a disease agent resulting from the production of specific antibodies by the host, either after exposure to the disease or after vaccination.
] |
